vTv Therapeutics
VTVT
21 hedge funds and large institutions have $3.4M invested in vTv Therapeutics in 2019 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
149% more capital invested
Capital invested by funds: $1.37M → $3.4M (+$2.03M)
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
24% more funds holding
Funds holding: 17 → 21 (+4)
5.62% more ownership
Funds ownership: 2.8% → 8.43% (+5.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$2.98M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$541K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$70K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$51.9K |
| 5 |
D.E. Shaw & Co
New York
|
+$47.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$106K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$79K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$47.4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$9.21K |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
-$2K |
VTVT Hedge Fund Activity: Q1 2019 in Review
21 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in vTv Therapeutics (VTVT) for Q1 2019, worth a combined $3.4M — up 149% from $1.37M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new VTVT positions and 3 closed out — a net gain of 4 holders — while 5 added to existing stakes and 3 trimmed.
The largest buyer was CVI Holdings, opening a new position worth an estimated $2.98M. The largest seller was Oxford Asset Management, exiting entirely with an estimated $106K sold.
- 21 institutional investors held vTv Therapeutics (VTVT) as of Q1 2019, up from 17 in Q4 2018.
- Funds reported $3.4M of vTv Therapeutics stock for Q1 2019, up 149% quarter-over-quarter.
- 7 funds opened new vTv Therapeutics positions in Q1 2019 and 3 closed out, a net change of +4 holders.
- The largest vTv Therapeutics buyer in Q1 2019 was CVI Holdings, an estimated $2.98M added.
- The largest vTv Therapeutics seller in Q1 2019 was Oxford Asset Management, an estimated $106K sold.
Based on aggregated 13F filings for Q1 2019.